{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {},
    "annotation_url": {
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert, Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Screening of a neuronal cell model of Tau pathology for therapeutic compounds",
      "version": "1.0.1"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc.genefamily-names.belns"
    },
    "namespaces_uncached": [],
    "path": "tau/pickhardt2018.bel",
    "pybel_version": "0.13.3-dev"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "As shown before, Tau aggregation (on the level of oligomeric and/or fibril aggregates) is toxic for cells.",
      "key": "e7e091a290a35f8814e6b186f3aa24e7c04c141be51c4b3fecc62be038e1f8607e927c0974bdef7c90c4dc28e58391de8ba1cafb78b5552e14f342f60e537f07",
      "line": 79,
      "relation": "increases",
      "source": 0,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "The dose response screening identified compounds related to the inhibition of 3 major targets led to inhibition of Tau aggregation: p38 MAPK (7 out of 8 compounds in the initial library), VEGFR1/2 (3 of 8) and TGF (3 of 10). ",
      "key": "9a90ef0332e10a64c63776eb916affbcb49fdedef359cad9747846ca4f5fcc5c5bf97b7bd79689d41822df4c8b5d627617f98092df9c481724c5273c22502efb",
      "line": 87,
      "relation": "increases",
      "source": 54,
      "subject": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "430606672d9718953a2ff568ad1f085350cab2f7ae70f34a192886124040f91d7399d903d3871b0fbc579e0de604100b14d779c1ad4647d711de9ebab5ded724",
      "line": 207,
      "relation": "association",
      "source": 54,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "994f202b50cc3ced84c86f9454f4a184e5dfe5a89d482b2a1623848484241d05a92835856aaf71c39e7b602985120e78bef3c0064a0860bbde7d07a266995716",
      "line": 208,
      "relation": "association",
      "source": 54,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "abba2132088df12fab5c006fe3f96b178afe8aa10fb08c3514cc1d0c5929ab44a62c460e11a8785a4d9578e33b3315094cafcb811fa72b29db996d60ea713385",
      "line": 220,
      "relation": "association",
      "source": 54,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "The dose response screening identified compounds related to the inhibition of 3 major targets led to inhibition of Tau aggregation: p38 MAPK (7 out of 8 compounds in the initial library), VEGFR1/2 (3 of 8) and TGF (3 of 10). ",
      "key": "b7db947076e7feca54b849e4abcdd271018dc3111138916f89797d2a4f41a7f9d33be4aa193949d9f14d50a59f93c9c98b79d09a4e99ed4e04b7f2a1cd6bd1c1",
      "line": 88,
      "relation": "increases",
      "source": 44,
      "subject": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "The dose response screening identified compounds related to the inhibition of 3 major targets led to inhibition of Tau aggregation: p38 MAPK (7 out of 8 compounds in the initial library), VEGFR1/2 (3 of 8) and TGF (3 of 10). ",
      "key": "2f41c0bd60a4699c47281c3dc59641ddb9b8a9179f7c4eee5e0ad082df66ae85cf6f38151a4a2e8d09bcde2d241d4ab02046ef10af495bee67083b4380a7236e",
      "line": 89,
      "relation": "increases",
      "source": 52,
      "subject": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "fb6bdd46e6a4d5d81b25fc5af48869e24b980f4e5b35bc8aa5f0cc616f1bc6b534f250667ff47a74e1db171be4999abe27e930505039d949e4a0ceecbde62463",
      "line": 202,
      "relation": "association",
      "source": 52,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "3f4fd5ce977e84096f898eb441011209262acc6239801db53c625df4f9444279da735cfdbaad8806e360d92169a9a32e0e81482d9c5e79dd25b3ea9cd14047fa",
      "line": 204,
      "relation": "association",
      "source": 52,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "The dose response screening identified compounds related to the inhibition of 3 major targets led to inhibition of Tau aggregation: p38 MAPK (7 out of 8 compounds in the initial library), VEGFR1/2 (3 of 8) and TGF (3 of 10). ",
      "key": "af3b143dec354f91f3b41f176cc807ac95ec96dca4383c28df0b1d1774817f0ef54e841de82bd3c33547d18a07711619d089cffa891182bc9b9c5d6201f379fd",
      "line": 90,
      "relation": "increases",
      "source": 39,
      "subject": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": " Conversely, compounds related to HDAC inhibition (16 of 20) led to enhanced Tau aggregation, suggesting that HDAC activity is important for suppressing aggregation",
      "key": "0056c2bd2b299d96b0de8efd59711e4178d10c001232f947db17e027fe4eb5ac7f484b125056260128bc2b76869ebb2401a31cadc9dc5a6afe9b58ee9b578184",
      "line": 97,
      "relation": "decreases",
      "source": 36,
      "subject": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "6ea1c0ca36c2084bb9d09876ed9b3cf67b9c8f54c70030045abc7e362920e95716f8c73ef61ab4a22bb0806dcbbfd996d6238e72fb76026f65f2e4dcce73ff35",
      "line": 185,
      "relation": "association",
      "source": 36,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Treatment with Givinostat (1.2 µM) lead to a nearly 7-fold increase in the fraction of ThS + cells (from ~ 12% to ~ 84%, Fig. S4A and B, blue lines) compared to the uninduced control, and 2.5-fold compared to the induced control. ",
      "key": "0cc991075302c23a66928499fcb4bfb66fe9c3f9171c17034c2a7b2aa49bf01e2c46ab9aa71c9b0ce8d7a7ed9a96f1115e940cee1292f477455941e3dd9e71ea",
      "line": 106,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 26,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Treatment with Givinostat (1.2 µM) lead to a nearly 7-fold increase in the fraction of ThS + cells (from ~ 12% to ~ 84%, Fig. S4A and B, blue lines) compared to the uninduced control, and 2.5-fold compared to the induced control. ",
      "key": "14862a3c1b52d5b49ac0ad210c7ee4f2658d0ebf5adc6cef68503c8718acd09d1a9d1baf8fedcf08fb5ab52dd766521c99d6e9b911bace7c72c3f208fc9f07a8",
      "line": 107,
      "relation": "increases",
      "source": 26,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "34029c9041ddcf70d3814dd7330b964fe4c22757c1179032c19918367e998887a02584ac98960b7327c5dacce257c81999aaef320c02d5d8f4cefe9b9f971ab0",
      "line": 155,
      "relation": "increases",
      "source": 28,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "cca4b03447f14867ec3f646b6f0a119db7ac09af5f403d28dee49877425c88cae9621eb38e021e446cacad93b9ae3c615b01c62d0fc219d57663a4b15c4f3406",
      "line": 185,
      "relation": "association",
      "source": 28,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "bb77766a346f634046a857ca9da7ce3863cb9d632db0b556230beb26e32afa6a8faa88e39079cc176f1fa8167e7b92353fc0d2a8167b137bc516478e10bb7256",
      "line": 156,
      "relation": "increases",
      "source": 11,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "a6bb8a0a5b7bc95c24ed3082bb61168f1738d711d4eb5c3f0b1db55f3908db7504ac7dc1de42dd760e4c089282f175112103443a4850362dd33a86d3e59154d8",
      "line": 186,
      "relation": "association",
      "source": 11,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "a68f5567395c5fe9d856e929e7ef8297343d28beed85644a50193dc02227ed1b0d50ecf40e22d59b6cf7d164b3feeb09a7283f8d8aa3d35fb24ce00fb5812b45",
      "line": 187,
      "relation": "association",
      "source": 11,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "fb4057c9446a2d7ec8db0657db9962be180436b7b433db1326579f3ac72cd6750b6060cfe1929c92d682faf9ab62c7d2ac40a79eb121b0ea40783bafabe880a0",
      "line": 157,
      "relation": "increases",
      "source": 8,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "52be505ca1743345e3a743c8cba094929ef8a9e095b2e67b66fbb76620f81d7268292e247b3731c6e5ea3761cdc8d47ae5324b350e52f7d2a966cd77ceaf1857",
      "line": 188,
      "relation": "association",
      "source": 8,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "c963f0dc6395b8afc88282dac47f79736ecc3a98affc5e45fd5a6ba3cfed8acd51da0fb73f72ab511c53c624ff3b0c06326eaf27e4285319080a5dba77bd3d7c",
      "line": 189,
      "relation": "association",
      "source": 8,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "3b90df7d2bba2fa016b621ca9a0d180e1840926046387878d87e247a6889ebffcfe09b1eb12884b3f99cfb7ccdb42634db2992acf74539af5feffc3f69290cc2",
      "line": 190,
      "relation": "association",
      "source": 8,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "2885369f227e2c19c88ef15b53777c0ae8f2c9202f53b95472bf8a29c7c4c63bfcead4598cd3d2b285319d8a444658d773e466f7351c57f57ac997d4a62b0d1b",
      "line": 191,
      "relation": "association",
      "source": 8,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "1605def93be2632895d6fab95de0683bc8ed3f1840bb7592ecbff1b1dd2c9491d75e483e8a23c50d3b7fc53f3a8eb759be84d6591c2761b8cf0ee114d946fe6b",
      "line": 158,
      "relation": "increases",
      "source": 14,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "3fa68089316f3623e6534668cad7714133723e1ecdeba8d7a3ff49cb20e43fafe4454001dfe5835eda89fde8eedfe5f37e12f6a78c3987d014062650c18b2b21",
      "line": 192,
      "relation": "association",
      "source": 14,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "79a81e04a794ea518a64b4e93834bd087772412d0ed1286e71ab3de04c28d9aacf2a8b96b98fecb00473066705b2e8948a4c36a090ec2adeed3713da78205d55",
      "line": 159,
      "relation": "increases",
      "source": 20,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "a75bf5f1b5d8dd71c89eced5a2e52c91c193a47376ba69e10cd08aa80a56c2006b4886a5ecf00a75094bac6e4656e0179010bc922e1422fcc0f00a1ff6dadb3d",
      "line": 193,
      "relation": "association",
      "source": 20,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9c1f9c1d774aaf4c531c1b2318bab552f6c4a45b5add2e1d3652b7bff39b74f06d082403b2fa40601e6e84b5e2594f265db09d2ebe7db5d284b1c50a6eb84604",
      "line": 194,
      "relation": "association",
      "source": 20,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "4389677146e4f4ce6fd5712ddfa2a72f3a1bcf5b34f4fdfeab43aeb5b58c39b27bba987968d3ed8a8fc7bd9245dca23bc9bd316642eea5a4a1264b098af4964c",
      "line": 160,
      "relation": "increases",
      "source": 24,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9567cd57ccc5a23c85284f87e9bc11cd6e0462bcb87e7644108c39baf3cd1d42e926b4424c25ad20f49bdbabe0c18bce499bb4af5ebe511860d03ca8560c2eee",
      "line": 195,
      "relation": "association",
      "source": 24,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "cb2a8a740c81a7ffea81a14e8b51992c1ad6f63f5f183208d56807c806fdc32a942ee19c518aae432711ac4091f07ef56aec66bed1934031745be08c306effed",
      "line": 196,
      "relation": "association",
      "source": 24,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ccd01bbafe80bb79afa6e6e19a71b8948548f105f5a926a9b9be1f3f4f128252dcf251cfcfb14df9adeb6445f55628cb76f9da3e30091d1089854ddef734d53e",
      "line": 161,
      "relation": "increases",
      "source": 12,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "c04de20629e1504b48690e055288d494bd36767412928941aede996103ea54fcb31e9710edf8986334a8482421bea71418fd21f74caba2436aa43ffa015edc08",
      "line": 197,
      "relation": "association",
      "source": 12,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "e5c5cac8103afcfc1469e1c1aa753c12723458cdf9713f918d7f48309bae6f94d8e67a407ea827a78b8be32be572dccf9d5c9263c9994fa8d210d01fcbebdf8a",
      "line": 162,
      "relation": "increases",
      "source": 9,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "8892492ba3776da3eaa9978363cc53f6935f435e50251dfafe402af5d28c9c68fa9163bd8615256c0705464879909efebf70159fa7c36080b13867d8fca2a1c5",
      "line": 198,
      "relation": "association",
      "source": 9,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "e6b196c018eecedfbacfe85f861e56102953b549ab3374782c24c9f58e30cfa55e263e359f3d32e966d5af5d9d48bcc73ef16194b50318b2154e26db17954248",
      "line": 163,
      "relation": "increases",
      "source": 25,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "7c968e8ceffa22baad5858b8f5f6cc8c2754e5e0872403c33cc08be3b56cf10004a55419b661d3c1c535f50f4577806551cad4bf2f74a6e16cbfee5bebb6c8c3",
      "line": 199,
      "relation": "association",
      "source": 25,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d926675230d0dadd2ebcd9648fb121ac95662b6d0c7a958e9057c83eb4e30bf68bbd419ead4f724498d83b7dc053d1b4e48510a26961c99f4b69de42b898cead",
      "line": 164,
      "relation": "increases",
      "source": 21,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "99c437ff9a11cf2b085c70b7634120a49b90e424b0e71a926deb37b5156275565e8413668982f5f6e51dfa727649da64219f2f24990c35d90e673deff36dfccd",
      "line": 200,
      "relation": "association",
      "source": 21,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "a0672df2e555cc56bc8b0903cb14a661b1d6117fb77ef77c77e95fadbdd86ab1f1478474f74ec68e636f552be2b702f75cad40ff3a754a67dcd6dd2290d32dea",
      "line": 166,
      "relation": "decreases",
      "source": 3,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "144f681ffde55520193f5fb294a6998c41b3fefc6d033206f1d4e7532c9881bbf3b5fa45f60c00ac0c2f17d9e3a72291a57feb3ca1641d8009a297614f6b1837",
      "line": 202,
      "relation": "association",
      "source": 3,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "29147db9f27dd1922e4b89bcb77c60957ba539f36dd3d0278416002d8bbbf32a9b54a79c7696cb19bf039e2a33448cef92135f625b34456fda29e1dccc4b4694",
      "line": 167,
      "relation": "decreases",
      "source": 15,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "35124e3e9a24a8af3505e34ee7526076fc8b7c0e8bf8865a363ba1379ebe3ec46f4cd8a80031444c3373ab971b6e6271d2365a4fe051a2a867d0a19b0b71b643",
      "line": 203,
      "relation": "association",
      "source": 15,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "03583bb545fd0de8bd71f83757879b5ffd4ac758e347c6fa7f59a75587e7a5b5bbed522dfe4057e045929ea139d98289d9c3e6a0d9157cffdea4f66f75fc140a",
      "line": 168,
      "relation": "decreases",
      "source": 4,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "8427f1a4c67ac019583f6a98404fb523f74aa92b7c831fe631dd07596753fc9371dc1cef3af4c27783362f20aa253789ccc1b86a7faa1587b5b496c998d4e36f",
      "line": 204,
      "relation": "association",
      "source": 4,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "288245b66ce33b861968465398c578898a3bb7e05b31d25c6bcc855e709b1164f8f4b16646a86ee70ec66755f04d135c7f24d8af8cc221703b4e209175fd20d9",
      "line": 169,
      "relation": "decreases",
      "source": 16,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "2c753bea8f82d3facf6d38a9134ab9478b463fbf38427ee2974b3c471429c3a3b858d8d82e9550894eb032a9897b8ede009ac4832f2bd75ac25daa8a2d841273",
      "line": 205,
      "relation": "association",
      "source": 16,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "30880599d5adefccfb8cfdce0a6a29844dcdf93de00cbdfd85ec2bc489b5cc53b14c823db934c3ee2f3e30e88ce6ad09c25e472f99349cb1f460ab8e0a3d385d",
      "line": 170,
      "relation": "decreases",
      "source": 23,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "029e4c54757671d3dd3e9e36d9fa6cf2dea47b7f3fe214776c01df95f345c43250bd434a24c4b3dec595a07084d9203754adf3b0f1d586d2b5c8166a9cd7df6a",
      "line": 206,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 23,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "a1816c41db28877a17218ec5ca5e4880ab4ed087b851919e1780bf3a8b8af7d0ca81305008400570c20d3582bbfe781c98b6a3236f9a3215cdba33e0c215cf40",
      "line": 171,
      "relation": "decreases",
      "source": 5,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "c99116ca0218ce82af29e3dcec9da7eed9f8432064f7127b61299a235a6063145dd8939492baf9f432ff3257b150df18310a511a166fea83248e736ec144483c",
      "line": 207,
      "relation": "association",
      "source": 5,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "8bfb1c3fa056e44b470f1b72d7bc3001291df711d1ab0cd7c1af3017553db822970dd253289f724b8f155feea762b4e53cde2f4791d14ad5e056b3b2d3a20dbd",
      "line": 172,
      "relation": "decreases",
      "source": 7,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "e5417bf0e721210455086815c5654f760f035fc889bdf6d53c147225718f43dac9970e75f7f2f56190ccc3e8ef477d9e8dc8dc8411317057292dd65e9b9a56b5",
      "line": 208,
      "relation": "association",
      "source": 7,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "e876cf289c746962d0b77289aacaa441c11b807e793142d6c3da2a61da402b7967553d23971964076debbdc335d98207e566c9899b5119c675b2922746d6b9c0",
      "line": 173,
      "relation": "decreases",
      "source": 29,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "68bc083f32a7cfaaa073ce025fc5ad8e5052fe6604dffda00568d3926cffe1d17895822a9d26ad167060e6d3e7b06f470f1bd976b41c3681a6884592ae7a9ed3",
      "line": 209,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 29,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "093f20d17bc9759a1c8abbfb46cd02f28153dc94868d20dcf99a259cac72f8e4c814c1ae863b9c3cf0ee33906071e91b18467a237484a920080963a9e3fc6f1e",
      "line": 174,
      "relation": "decreases",
      "source": 10,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "2ae611ba628fc93a2b55974bc58d432d8b9fe6ddf24e9813c7cb34a251711d45e477300e71caf9b4acde951d7efbdda0ee8e3634e8052cfa45cb5f5c0c1ae34e",
      "line": 210,
      "relation": "association",
      "source": 10,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "b2e347ae2b90d5375c59b2f8273d0e0cd1cf2aba5bf6d12b75a3d99c62a6d28f188a52b4366eaed505fd1b3655469228a249570cd3073bbcd135b5d9daffe11f",
      "line": 175,
      "relation": "decreases",
      "source": 19,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "4741f3d86be279e876c73ca3a47c69e711b48bedb67b12d27a15094a790b13121e0a0816ba751d810b7b06e2638280ea6d0382675e632aa7d9a86d871b3a98d5",
      "line": 211,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 19,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "259d40317fda5bb408cf6ede0ec44e9586198547995a70cbda199f61aafc4465eb0f4996098b853b94ff66cf8a9669e6700160a9aa79c759dff2af2b16fc0088",
      "line": 176,
      "relation": "decreases",
      "source": 18,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f921edb57044d58be92db1f6795d356e5d073853dadd5591983b7b9fdfc614228d5a8314d4e05d8627b8dceabe6b770ec08746615a7a21201153c63ba6cd5344",
      "line": 212,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 18,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "1b893e4c35815d30d958f7cac1f7a0fd10b42650c999dd2e3f04339113a41871b1ed49869baa166a04f436f189468f74fe9397a5f308cab77b6e226c6807fb44",
      "line": 177,
      "relation": "decreases",
      "source": 27,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f5912cd13ebd7e96918a5fba0df3a302071713d389ba849ca7ad98a315f1a88cb369ef8ee83e526e70d1f2ce06cda98761757286367020404613045e13251436",
      "line": 213,
      "relation": "association",
      "source": 27,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "fb97c592d4dd36fc9c7e8b97132095f3d08d01143e090d40a3e219aa5cd998dcce7fda9cbf09af42fec4636c1a47ce72c541f2294e36ea317d9291bc373e49b1",
      "line": 214,
      "relation": "association",
      "source": 27,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "196cd56da1f6bc0d89dc2bb4bca945b04636477712ac9b9c9530ffdf8a7a43fa6f6c86f9464e08daca96fedda74a952607baf37cb163657e902661f534e2281d",
      "line": 178,
      "relation": "decreases",
      "source": 13,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "80c3ce66588a14dfe92c9f2d8a5750735c2c85e4ff5993a76a22c7c725fe92f8f13d747ad6c9439fd305d4bdb8a5f52cf1cef39a0ab17c291d129d5f6c6c0b0b",
      "line": 215,
      "relation": "association",
      "source": 13,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "bf4f695113a41ba36713c863b185aa794c6eb563dd2ab96cefe073cab42412ecbbcb3a435deeecdc9c83a3dbc6eef952d9ee1535a1fc41eb68ee759f8afb1dfd",
      "line": 179,
      "relation": "decreases",
      "source": 6,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d03da25b28948d8dca2b027387bd93a36f34fa8d65da398242bef0d9f8bf67669035c568501cf88de1ae80f97bc876f25ed5f9da97a2b6c95314f0cba2e8c346",
      "line": 216,
      "relation": "association",
      "source": 6,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d5aa276a4bbccc5f88ab709b490f934c93501523a9da654b7d136537d393c04a3758b8b2367fec7876ecb8bd0eb0c1195a0b7ba84f195941c501ce4f62602822",
      "line": 217,
      "relation": "association",
      "source": 6,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "5c38627208fa81b38b85d1d5f7bc3ec201ed8df2d9cfa8e7c088895c8cea86d0da2f9443280f8c499369475518dfc15017fce88ad9c347e7c55038f8a22af620",
      "line": 180,
      "relation": "decreases",
      "source": 2,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f6a1baaeaf8d6c461c5ef4184b666ffc3127ebbc5e1b1e20e655944b56a8cdfd3cc91106fbb86213daad9be9249930a04addb0aef6c0866e206c97efa4704f7b",
      "line": 218,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "bdaea5a8420bdae42090b7df8092133fd87e1b177b3206bc24e474778521f7b5d4f2efdc42089a61fbe07fc02402b5bd297555c618a320333f40b5b405df443a",
      "line": 181,
      "relation": "decreases",
      "source": 22,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "74ea3aefc818a0b06012eeb0d3e42025ab910e77542782e1ac7b5001318e3301a9625a60c539aface70cda876a65621c84c9f52a37dc639f24166a36f54f307a",
      "line": 219,
      "relation": "association",
      "source": 22,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "1984c17d38c300bc9c997973400ada7da736bbc8d969b8152a9d58aff67462f3716cb4a593b61d71c6f35c3090ac7284e737b45ef437829ef16143f6dbaa166c",
      "line": 182,
      "relation": "decreases",
      "source": 1,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "b41fe1c036002ad76ec7057f4fdb1b45a84da821ac95a5b4139177887d3ed64f6df1921cda6e4114bf6367ae40fb0b6315d8f2ec40f9e831193594631c85c892",
      "line": 220,
      "relation": "association",
      "source": 1,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "6ec26804d7c42e31443db3c6e775d905c69a588c0e3d663c441fa881c4ad6de85e7ed57cc307b845a03c74758f7a22588dda13056abf1c580e7afa0a55835152",
      "line": 183,
      "relation": "decreases",
      "source": 17,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "f19bc82e6bcc1060c8413db35431c47d90451fc1c1bddd301b21bc1cfb7b26c21751cadac934fd4eb70b7d4926cca5a3f54d7a1d607ae745df1bac9baf5c7463",
      "line": 221,
      "relation": "association",
      "source": 17,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ebbffa4a7b5b3d4f589e4bf8f64f59684e9e783773dde3122fe6b7f8155b3ec00ca9d83ebc6a41a14520dfe69f17b3b2dc6127195a1e40c499676a3194c36188",
      "line": 222,
      "relation": "association",
      "source": 17,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "018bf47e453fded4698e56d88a6d181a18e3ce817c68bd4eaa3252aac485857205174cdf25ccde4728217dacbfb58ad343a938048f4f51231d5ae55aa6b8854c",
      "line": 186,
      "relation": "association",
      "source": 48,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "bb5360b975a12a7b71116936389db4bd546d048f2364a8e4f09cf143fc25bbcadc0ef2d72d2016b92e2252f6d14e3d6faf043a8d7aef65189f4f73abfd8c274b",
      "line": 187,
      "relation": "association",
      "source": 49,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "b8ee205e385935078664545fc2558214f93db90fa9be785bc2db4d7f8ae9462b7c8d5569cb960f072c4ff874373808f2dfbc91c7042a87bef1a32ef903249665",
      "line": 188,
      "relation": "association",
      "source": 32,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9e5a53b1115189c790fbb22fb355d7b237718aec9c9dc6fc157485c7c7f069500cf4dece4b1e398925f8fc1b01010d3cb0bc12dcb0763c695a6d1b3808f6f45e",
      "line": 198,
      "relation": "association",
      "source": 32,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "772957c3f4747c168e3f64da48e1b64c3e7c71e3f35567a7d2dbdc4d36b3132405e1198e706cda1b37fb483013dd62828c48536c850a3e6332907eea0d5ba30b",
      "line": 189,
      "relation": "association",
      "source": 33,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "a4d33dbbd415fd373bc47812503e7db5ddb4e3df096623e4c57e4ebd2c421620d225a96f4dfd69e8c588510e2b6da5c9cc89e88936c156e24fb98d41cd540958",
      "line": 190,
      "relation": "association",
      "source": 42,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "b28a3dc51bea82ec31e45ea565d851c82706aae4069b7bb35f85ccdc0ffcafa7aa62dba1747f4e50d67c7158d51c43d7158ded43f0ef409257d3e536a1e0ec31",
      "line": 191,
      "relation": "association",
      "source": 43,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "2167311ee6cdf906af95e5f2e5f52c01a0201d16591b134306fd937e04b8e55c406bc8cc7e494f527a123c885ec6836c2aa92f7888c3c2f43faa26351cd1c55c",
      "line": 192,
      "relation": "association",
      "source": 35,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "4ed80188bd917bf912ec49322bcdb191b6e8501bb29b4df054af0e91168f0ec954e4dcacc180c7595c9c69254464399300af151e92e998d2a874bfe6699702f3",
      "line": 193,
      "relation": "association",
      "source": 37,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9e02ad730f56bb8eda7dc180cf330094ad1ea347668a121af6acce23e4c37b8e48ca2e574fbe38fc43b93af839d98d144f8058f7438f59532ee4b15ae36dd284",
      "line": 194,
      "relation": "association",
      "source": 34,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "b92f27fd161c10bac3d93d66b051c666dcfbed86c7d662e88c023010936e582a8193f2cbec73e199bdbf273c58d727c72c794437452b07a190ec2530248a52e0",
      "line": 195,
      "relation": "association",
      "source": 46,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "45a85fd34993695d9c36238fd5a62b68ec0a8c6af7d95450dcf27b982cb53e4483d96621be9bfb09f8386fbc7fb0c35a5579b37614f9674dde780b91a96d52d3",
      "line": 196,
      "relation": "association",
      "source": 47,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "4847be05fd79b9eb2b4ceefd1248e14dc22e35254737f975581bdb75ece436f3fddd6cfcb103bcdd46e16cf0acb30edba8f694fd442df8c0314fe0b2730b654e",
      "line": 197,
      "relation": "association",
      "source": 55,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "0332b658f1dcfe82461e2ac5c83dce7d2f0abc9b62429aacdc38c35ba40f5247757d7750fbc792d3e2a894b5d53f08af4cb672acbf0998bc4fbf5219cb75b0c0",
      "line": 199,
      "relation": "association",
      "source": 61,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "c1f3805ff6568adfe8b37a5a383b194b403536863934f5d713a93c45a34f5f9d7024fcbf25926501432fdbe01ca1ac91b3b5f0bbd73f76c800d8953fb97ad3bd",
      "line": 200,
      "relation": "association",
      "source": 50,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ed863e734d34102f2941dbd7be8ccd7990dd3e4020330b87f193f74161d1b34017eddaa227f620fa6251816d807eaee878edc2141775346428046f83644ddc68",
      "line": 203,
      "relation": "association",
      "source": 57,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "6e0d7ceb11902c534b24997a4ab0eba42e33d80bec359e39555756823b34f2552034326ad7896e78e59fe208c3b1bf3a89aea2f0414e32183797a7cf3f5c11a5",
      "line": 215,
      "relation": "association",
      "source": 57,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "e79a7396763edf35783b0ea6bfabb730a3a16914debd14974635243ef17b69aa3d20f8e7a6dedded1cdf979859b20cc36235574c5a10c7a7d684b2ae071667a1",
      "line": 216,
      "relation": "association",
      "source": 57,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "9bad913dfcd9e28c7457630f947704329ca9fa1f41fff9ebef9b71a4a35d55a9afc24d1f772c848cd17812b0a376a20f443033599c7aba7118acf9371aa7dadd",
      "line": 205,
      "relation": "association",
      "source": 38,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "ab3d523c3a65844852941fef9d67f8d85cec2e75e364552ffbd389b01fc0cfc80df446cde2d317ee4b6545e14365247e8e8b1afe759ca4074e0d03bec0e5a782",
      "line": 219,
      "relation": "association",
      "source": 41,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "4a377b91a476b754446ee65ade96ec334053bff491ad9357e64734a6dae5d27a0fc6de66c4a6d1cf0884c3e551b96a193ab61515aa6e8ba84666c1974c56320d",
      "line": 210,
      "relation": "association",
      "source": 59,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "dbe0abf795fc83aeeacd4a45b54d9bfc368c8771a873f125f3cc56ecce1e6554d3c96775e1f97df15a964d6c0deba704d0f3561cfd2ca4ec36418e73d8e1e1b6",
      "line": 213,
      "relation": "association",
      "source": 56,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "81a36262eaa211ccb4989585c63f5c87ddf3d4ccde5879be3e2162c1cfe407a70369f3cac2b7879b3c4dc2b606a9ddc1f673a229ab225e1eabbab2ebc35be13e",
      "line": 214,
      "relation": "association",
      "source": 51,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "d74d902980eff6bafe2bb24438298cb98a4dc22d64bea17cb82203994033c6f80f71d766dd472680975234a249f94137fcbe44c3fb4a6bbf1bbf15ae4d971e0f",
      "line": 217,
      "relation": "association",
      "source": 58,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "cec464ea9837bb7400a1a5262a2698cdbec8697ff744f18f44e497387e61c72ac57fbd5019ac6f35043727a09f857cf738e47fd51eb82821d0d1bca9f95d8e13",
      "line": 221,
      "relation": "association",
      "source": 53,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Denner P",
          "Fava E",
          "Kitanovic A",
          "Kurkowsky B",
          "Mandelkow E",
          "Möhl C",
          "Pickhardt M",
          "Tassoni M"
        ],
        "date": "2019-04-01",
        "first": "Pickhardt M",
        "last": "Mandelkow E",
        "name": "Neurobiology of aging",
        "pages": "24-34",
        "reference": "30640040",
        "title": "Screening of a neuronal cell model of tau pathology for therapeutic compounds.",
        "type": "PubMed",
        "volume": "76"
      },
      "evidence": "Tab. 1A-B: Summary of the Tau aggregation modulators (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease / increase in the amount of ThS + cells without affecting the expression level of TauRD∆K compared to the compound untreated control. ",
      "key": "65caa78d8c3fe183a072d86fec7f858dfd688ea4d071646e290865f9b482fbff32d55cb49bbe07f8e3fa3274d3bb220725b1fe9f4b5230147510a875befd416d",
      "line": 222,
      "relation": "association",
      "source": 45,
      "target": 17
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(HBP:\"Tau aggregates\")",
      "function": "Abundance",
      "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7",
      "name": "Tau aggregates",
      "namespace": "HBP"
    },
    {
      "bel": "a(PUBCHEM:10341154)",
      "function": "Abundance",
      "id": "72165a0323eb738ff5aa95f0667cd0ff62205290b798476019cf5dea962368284245340168f0fec907930ba9c76ec5519721ab5cf37464cba89e82def2a4e1b7",
      "name": "10341154",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:10435235)",
      "function": "Abundance",
      "id": "a5c5db5544c73e9d94b91976381fe31972ae5a7f3a892cdfb352a1e931e0c9aa5e97ccf7bc8dbf8b969486c580a99965669a86386e973e63a8cf51d565db7e82",
      "name": "10435235",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:11154925)",
      "function": "Abundance",
      "id": "61f04137eaef4a9fe1f5f40bba9a73a26e7e66a006b34442879bc0ae8ad7480dbd7a05627d2558805b50f2ccad3e7f0ef434608d784faa9e99b718fdcb0633b1",
      "name": "11154925",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:11234052)",
      "function": "Abundance",
      "id": "8ee28904cdc4f245773949d1231bacfcbde5db73480da4f4cd76bb437c7c57e6558fdfc0f94aa8209da498235e86e00d299a300378abcac81da868e7d21a7b9c",
      "name": "11234052",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:11570805)",
      "function": "Abundance",
      "id": "a3d0fccec3e5ebd1ce5756bc19de47c81f3030af4e9ace855f032046abf053494382d22996648eebfda42130442bade5059582ff346ad12de4f035b39b48fa36",
      "name": "11570805",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:11655119)",
      "function": "Abundance",
      "id": "0a7e5684f46d4fe99b2536c30bb982df35d67e11922ed5f727e7a2fdf7b20bdfa897a04bbdd7310fb9f3c107cae59f3f599080b1d89f946374117aec5f8f5c80",
      "name": "11655119",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:156422)",
      "function": "Abundance",
      "id": "6e7951db3538d8eae00a37e3a8376da89696c060b657fc5966559723fcfb6e3e883871fb83be44a3a7211f65204ad5851db52cc1c4773ea8324356a4ee086173",
      "name": "156422",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:24756910)",
      "function": "Abundance",
      "id": "9373722643396b79eea38526cfe7ba0d940e28b1161acd44d8dd70024783c1cc958193ce824b2d541ee6921f77a1b74b5d10fbecb69c643cb29f782e2bc2fd62",
      "name": "24756910",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:2746)",
      "function": "Abundance",
      "id": "4e10dddee73c172deebd09c56a6f7c360f4c2ca03257a1f42a84bbc09223f9c3f9fb6948e2ea8b7be376a43881b020c5c089169e59ad65442f9163c123416383",
      "name": "2746",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:3033825)",
      "function": "Abundance",
      "id": "265752df3362a1ed7a2afee7958333323285f1382ba4dc39b7ef99c79ce79613df1c8f8cdca6ee54e6f273b1d90cebb24a85479c7dbbda8795e1a63d842c9b64",
      "name": "3033825",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:4261)",
      "function": "Abundance",
      "id": "70ed32c4ae9da5fd20f23dc02d7b07b13dad48c0161766d78c07ea951d1e4da83d6b8d6abc32901686715238e33c1490c0e01476f409118d255a7aff45f1c8fe",
      "name": "4261",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:42640)",
      "function": "Abundance",
      "id": "94662527255c7cc5d33e13652d430b80d0fad41653c168b22ab2566abeb07b440a8db26d3c304195dce0bae9ebf0b36cbdfc1285543b353d5801dafdecf7c364",
      "name": "42640",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:447966)",
      "function": "Abundance",
      "id": "2277e50c8ef91c82b034775762d2d6ef279ac24e374fa9beddb5916be179fd32a175ebcb7ade9946a27e6f0be2b38eb1b86e176f57217d4819bd93cc3f77021b",
      "name": "447966",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:448537)",
      "function": "Abundance",
      "id": "7877b346dec95db0719a0f1f0a89c5bc25c2e8c1c34816e2ff42353fb4cf2cb62f56ff8604499ce8856d61bc9bd36a406ff273373b9543b5f756da140979a4b2",
      "name": "448537",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:4521392)",
      "function": "Abundance",
      "id": "252e89028ca9e540a504462ae34dc79e85c4981470a8516d1ad29775d2e1b0be540264a1fe7f43a197bc9f07610b00ca2c7ddd878de4ce447195ad1fb507db83",
      "name": "4521392",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:46209426)",
      "function": "Abundance",
      "id": "de4500853a5d54d631a7c710b3edcf2562b96ce4dcb5f6e7a6b7005e4d7828597f8ad1093eeb7ee28f095fd5d46e191dbb2e2fd53dd6cacb3f42c632d9360d8e",
      "name": "46209426",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:4878)",
      "function": "Abundance",
      "id": "d0f62a21821bd85a4a85b574e9fc7cffa0285fa0b8b31ee1e4846718ea4fe2b4f70c1806fad73107b73de62a60c1afb17145799fb567b191618a7af69fad8112",
      "name": "4878",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:49806720)",
      "function": "Abundance",
      "id": "579c09e581b0a7c00c60081b8cfd3cbf35b2c0be5fef39f24b63c9ffcc9614abb316dc068377f46de2060cdb93989b44ef294f67cfdbb6ef96c99578a031cb4a",
      "name": "49806720",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:5311272)",
      "function": "Abundance",
      "id": "d561f89e6f2880c7a4569412d8a6173c9e128f43a2489bf0cc95b665faca068633eb430f5d152e1cd0a97f48a3120e74dd8391dfbe88bc1f6ecfd68dba4a0269",
      "name": "5311272",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:5318517)",
      "function": "Abundance",
      "id": "dd5f28c1ca7aa012e2c7a3b03a04fd71786f918e921e399fddc3586c09245d75397b252a497a45c8a9a2ecb710e9dbc5752d5ad4e86e7401edd0718593df1f33",
      "name": "5318517",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:53340666)",
      "function": "Abundance",
      "id": "0ad0237ec79c717fcacceb700329a45018416a7dde687a608d7d4b71bf9bf04c187c1e2994f7554298ee37192aba3ee41648a227602b32444159111775e8691e",
      "name": "53340666",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:5833)",
      "function": "Abundance",
      "id": "e6b38ec8876a34ea8b48ea43fc439804782d62ebedf04b34c976dea31fb6a77a944e4f7ecb55523c8f75db55f8b228d05968a4cd4f1d8dd2a35ff12638f7e1bf",
      "name": "5833",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:6321424)",
      "function": "Abundance",
      "id": "a05510bee39bfbb4eff2ca4791eb5ddd88b044c97cbbc9ba7de292cfa9d3ef7c09f0b5f714c2e0be9967784f2798b6dc78c68d7e41447e5431e02b3544785c4d",
      "name": "6321424",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:71295844)",
      "function": "Abundance",
      "id": "92da0934f56d6fed1ade12e73a32ac4079af25e8db96495fe40d4ec89be1d560e6ecd5b341e595ae9a28a667bb1f4e6857faf0242c8281dc1729752f2b10013f",
      "name": "71295844",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:71729974)",
      "function": "Abundance",
      "id": "d68bd9533100f62341358f711c283f0d985ddb99ad51f25856b20d8986628ab79cf3e288f4fe92d964391370c1e79ae35c4ec982aa5d6572f8a90d9eb11d8d6a",
      "name": "71729974",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:9804992)",
      "function": "Abundance",
      "id": "6f79694353be6aa83ba7a32f5210fa94c7e4e978d62c3ca8573f226930dcc00b0c32b9239953be791ba427864f8a244ef5c838bf626652f6f0ce9e00cfd322be",
      "name": "9804992",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:9839311)",
      "function": "Abundance",
      "id": "6ba5157cd5e0ec07e3f043850da7ce0dc73dcfb32c478eb1bb5cfceec7dc4d5c29c1ee54e451c22b4c33227362e9508629447f292453a72f4b70c5e9c41db1f5",
      "name": "9839311",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:9865515)",
      "function": "Abundance",
      "id": "55a9dd49a78f2347290ea268d0df119c7cec51ee30ffd3ae35545c39624cb95199221d34f2efd247a5f76e1a0df8579b9a0dc1ee9016a977cc929f5433abebeb",
      "name": "9865515",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:9880)",
      "function": "Abundance",
      "id": "1decfa5163486f53b4003a059b406d1922315256378b001c7b6f4a803f2ef52775d5b9b7cbe14a665db486edaf4919944dc23573952cc667f62438c6c7bddd80",
      "name": "9880",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "bp(GO:\"cell killing\")",
      "function": "BiologicalProcess",
      "id": "a8cd384051eab3afc577d2e25de7b7402e672d30b248837ab57d3f859f8e719b15f3a39935a4a994a175ef384bb0751a54450aa96caa52e780653bce27962098",
      "name": "cell killing",
      "namespace": "GO"
    },
    {
      "bel": "p(FPLX:\"Gamma_secretase\")",
      "function": "Protein",
      "id": "99713174fec183dbce7064ce1acd26970ee41a511f23df4d371fd5278c633824e492dd22684d4b64d57643ad528d90992950c5a00b1bc6870245e83c2953a132",
      "name": "Gamma_secretase",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:\"HDAC_I\")",
      "function": "Protein",
      "id": "7b1a93ff7b9e17d1e79b9504a268337483328d3f0597cc50fb9a6834dfecf4d87a3fca90ba30319be77289b3d4b3818664715486dfcb3a4502b59db588d970c7",
      "name": "HDAC_I",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:\"HDAC_II\")",
      "function": "Protein",
      "id": "674fdd3fec5d6cb8ba4bde4f94fecb2cf4c6bfde95bba6a5cfc803769f0a1be436a6223c049ab32f7049b968fab092aa5a9bcbec781afc7a18cb91469eaaf798",
      "name": "HDAC_II",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:Actin)",
      "function": "Protein",
      "id": "57be0b6b7401099817c1860652cc169ac7862887c6a0457ffdf332de6f902939dcf65a93980fa9ef23187a476b3f87dd815b35d6149488db50800f1ed5fc6685",
      "name": "Actin",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:ESR)",
      "function": "Protein",
      "id": "68ddde6a327a4a79a229d5f773d7ce6de5702888d0ff599d47b2fcb519b465c0360c699a6db7433a3dfcc48cf3c8e10c074296da492148b539839287a76e4ba5",
      "name": "ESR",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:HDAC)",
      "function": "Protein",
      "id": "d2e8833ff804c3b8c5a045ac8a4096c1c66c61101c9ed5ce1f0c355bf74149b9cec6584bc3e5186e942bbd700bdafa9ccf9bab0127fad62731702159604e5ab5",
      "name": "HDAC",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:NFkappaB)",
      "function": "Protein",
      "id": "a76f3010d13c4b506ba95e6e6bef897dc400ea1bad5f8288ce4b084f2b57f9e7aa59f5146eff656ed56a6d2077d5907c41cbd4539f26d63411b79ffe7179e54a",
      "name": "NFkappaB",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:ROCK)",
      "function": "Protein",
      "id": "e8aaf7fba8f07575a0539630a0192e471ed32e61c51df2ed44d02a95df4e9073a52c2f4c76e3b953515796882b73fe8c36a46bf0c5d18c9a51c4276095b6e4bd",
      "name": "ROCK",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:TGFB)",
      "function": "Protein",
      "id": "e86a98227b2633c3a1aa8b95cea5f70d7fda9d82fa218385267d86ae1f8c87130561fa557ec942100f3fd9030a9ea3e28842d3e26938e485745c281bdb3b13a0",
      "name": "TGFB",
      "namespace": "FPLX"
    },
    {
      "bel": "p(HGNC:ALK)",
      "function": "Protein",
      "id": "64650d07069b4be745ed76fa2233347300da6bf1768219a5a8b341c0e21b642a25a5421485c816f370720308049077c192b180d974ebff7909dd38ba6d9ebb65",
      "name": "ALK",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:AR)",
      "function": "Protein",
      "id": "60878547f1ea9bd206acace30325a383d895de7264633382bdeaf9a3908587be2d24d753a66f2072ea329790851aff35688463694a4afe62906b3e18e1c2d643",
      "name": "AR",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:EGFR)",
      "function": "Protein",
      "id": "4954e4f8dc1de58ed814b8317fd25599aeb80e46c4d436df48c4f2bc563c4f72ab93e9644c1fcc569a2c5d18a39714827469ba59477629a368c12331ed03c71e",
      "name": "EGFR",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ERBB2)",
      "function": "Protein",
      "id": "dcd21f91b4b3e8279a275c45587fe249a2e070eb2feb480a84b7d4a8ac14dcdca1ec2010b4de784666ac69771aee6d5036fac0f6074d87c997c24159d1504ee1",
      "name": "ERBB2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:FLT1)",
      "function": "Protein",
      "id": "c2bedf1863b47ac419b2f67f8e60153bf9390396a6d7067e2f42eb9d30102f2586dfd66a49e22fb2f6276968403b3cb11843256bca1e710124754f2d5d63b0d1",
      "name": "FLT1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:FYN)",
      "function": "Protein",
      "id": "ecffd0427f2e321c9ed5143ca2510464c2fef5432457c332ee991bda79dbdd12ace6375208ee66760cc5b9b7990248651b41a370f16eb9459d2b8682cb0da86b",
      "name": "FYN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GSK3A)",
      "function": "Protein",
      "id": "4dcc5c23063ff0124b5d1cbb5234bc651bda68ab1675a7f4f5a55b966f6e2a610cd47d0b43d14895e16bc8e506da0f6d265a5d9c7490c754631596b2536de8f0",
      "name": "GSK3A",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "function": "Protein",
      "id": "ac819ecac7786e3ea9b6906b318167c6a94fbbf428aff46f85083b83c50b9604342d39c1c36ff49c2cb3a04e491913164c3e4e7889dedd513b6196d9b0560c7c",
      "name": "GSK3B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:HDAC1)",
      "function": "Protein",
      "id": "7e59d21e05ae903eb4b41fa4970d2e6858428aa39729cbfa33f2f675f83b53a0f7fac31cc12dd37ef5dd0ab7af6e4dafe18b90e09a8e5b63d454e0d39d9cad60",
      "name": "HDAC1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:HDAC3)",
      "function": "Protein",
      "id": "9378a13aecaaef25a186c551ad4aed40a80541936c0688c1526e41e8d457d9e545b08435a44058b7bed2eb5753775a5cca704ffd7a7fd998ce2c5f8b21914668",
      "name": "HDAC3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:HDAC6)",
      "function": "Protein",
      "id": "c6e2cb3c91ba614ec9e19574656eba9d234344b755f57479d99a4d4ff77acc4917594446b9b19f9823e8a8a0d2d457d74b6f6a582d9f360f13df4136d902c7c3",
      "name": "HDAC6",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ICAM1)",
      "function": "Protein",
      "id": "62f213f2262719b575fb019b72ed869992c5673a697ff650aa80f47bba29d5762dc9a109e772c69d04e02b3b2598b42dac9b34a2d306bc31ed1a4cd095e32dcd",
      "name": "ICAM1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:KDR)",
      "function": "Protein",
      "id": "b6e3ffe343f837de7be1984fca8481b3905f35bbe4b632df1a513fec7a864d553ecdb61355eb2f2e3a4fc13a2d90d839a2cca5f07a6119cbe6d72b7be162e3e6",
      "name": "KDR",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LCK)",
      "function": "Protein",
      "id": "e01a7494db504930dec972b29f8a1db10e5b225cb2e9bdefb8a546f8604798b462417e23959e15a82df474279bb080449967ba87d4fa84bac141b8446b229ccf",
      "name": "LCK",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPK14)",
      "function": "Protein",
      "id": "7c10ba4aa52bc8cb24fca9be53229a6eafa3cf7979169443f5748eac1db12270556317043e9ffdd7e8ad9225bf8825aa187b298f8566ac3c3e8ae485a0ce8656",
      "name": "MAPK14",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MDM4)",
      "function": "Protein",
      "id": "a60fbb55611c188e02a4c397536917f21fb83f38dfd98a1898dcea71b9c9cb42853c3aaa6d205e42074f5054450bf69b034fe60fa6ac46aea1c359129b241c94",
      "name": "MDM4",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SELE)",
      "function": "Protein",
      "id": "4a8e5da50c34333c8ec073ae3db464d329c8f7c5d826bf774dc0644411ce5bcf8932083f4d696a40e71e50d6a9bc6bd29342c77393201c77f3f432a890128fc4",
      "name": "SELE",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TGFBR1)",
      "function": "Protein",
      "id": "3c5cc11a573c91fb3e12ef9c40a7d38445db1bc8bcc23ddc1d6b9b90ca4913614368aa8ea573d78ce5eac5f00b32cbef7504ddee733786005b4f272b72644f86",
      "name": "TGFBR1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TGFBR2)",
      "function": "Protein",
      "id": "98eba82f5cb92f110eb0d774a7fc518a60175a78071001860ce028fae4495b2a47128feb8f881198477a8b1f29cfa1329eb887f0ef84e23df6af0543b526fc4d",
      "name": "TGFBR2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TNC)",
      "function": "Protein",
      "id": "38802a9925d2d342abab97c2647a8fa9969cd2c2476392a4fb208b2e54896f6e8e8a41476b03b004437480425c1e9d8cbfbec7d901663b0f3bc167c73721ee64",
      "name": "TNC",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Chloride channel accessory\")",
      "function": "Protein",
      "id": "86a6b480ec464a0a9efff1c2f9a5cb7ee1c79dd025a56c58b35d7806853c797434931fb9adfcaf68057dee6a07f9ea4ae20b051004ec6828d01d8ae2c88da618",
      "name": "Chloride channel accessory",
      "namespace": "HGNCGENEFAMILY"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Lysine demethylases\")",
      "function": "Protein",
      "id": "8b30f00110ffde027c6eb8c9ab390656a7a1d48766647206956fad697dc1d8df04a4d9b46d5cbf9d734e9606a33c753431283e349feb4e1b5e00031dc285e4ec",
      "name": "Lysine demethylases",
      "namespace": "HGNCGENEFAMILY"
    }
  ]
}